The DOI matches its Crossref record; 35 of the 38 references it cites were found in a registry or an index.
Indoleamine 2,3-dioxygenase. Purification and some properties
Open accessAbstract
Indoleamine 2,3-dioxygenase was purified from rabbit small intestine to apparent homogeneity as judged by polyacrylamide gel electrophoresis and analytical ultracentrifugation. The native enzyme was a monomeric protein of a molecular weight of 41,000 +/- 1,000 with an s020,w value of 3.45 S. It had a relative abundance of hydrophobic amino acids such as valine, leucine, and isoleucine, and contained approximately 5% carbohydrate by weight. The estimated content of sugar residues per mol of enzyme was: galactose, 1.2; mannose, 2.6; N-acetylglucosamine, 5.2; and sialic acid, 0.8. One mole of enzyme had 0.8 mol of protoheme IX as a prosthetic group. However, copper was not detected in a significant amount and the ratio of copper to heme was less than 0.03. EPR spectra of the nitric oxide complex of the ferrous enzyme indicated that a nitrogen atom, possibly in an imidazole group, might be coordinated as the fifth ligand of the heme coenzyme. The anisotropic g values were gx = 2.08, gy = 1.98, and gz = 2.01. A single enzyme protein catalyzed the oxygenative ring cleavage of D- and L-tryptophan, D- and L-5-hydroxytryptophan, tryptamine, and serotonin. In addition, the purified enzyme had a peroxidase activity with guaiacol and potassium iodide as hydrogen donors, but not a catalase activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased IDO expression is responsible for the catabolism of TRP in the KYN degradation pathway [36] and is canonically upregulated by inflammatory mechanisms [37,38].”
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 16,688
DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *
Davis, B. J. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1964.tb14213.x · Cited by 16,129
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Automatic recording apparatus for use in the chromatography of amino acids.
Moore, S., Spackman, D., & Stein, W. (1958) · Federation proceedings · doi:10.1021/ac60139a006 · Cited by 8,126
The thiobarbituric acid assay of sialic acids.
Warren, L. (1959) · Journal of Biological Chemistry · doi:10.1016/0076-6879(63)06207-8 · Cited by 5,607
Disk Electrophoresis of Basic Proteins and Peptides on Polyacrylamide Gels
Reisfeld, R., Lewis, U., & Williams, D. E. (1962) · Nature · doi:10.1038/195281a0 · Cited by 2,569
Glycoprotein staining following electrophoresis on acrylamide gels.
Zacharius, R. M., Zell, T., Morrison, J., & Woodlock, J. J. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90383-2 · Cited by 1,770
A theory of gel filtration and its exeperimental verification
Laurent, T., & Killander, J. (1964) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)86637-6 · Cited by 1,352
Research works printed but not linked: 12
- Yamamoto, 1967, J. Biol. Chem., 242, 5260, 10.1016/S0021-9258(18)99420-2 · DOI
- Hayaishi, 1975, FEBS Proc. Meet., 40, 131
- Knox, 1955, Methods Enzymol., 2, 246
- Gerlach, 1974, 2, 569
- Putter, 1974, 2, 685
- Chance, 1955, Methods Enzymol., 2, 764, 10.1016/S0076-6879(55)02300-8 · DOI
- Siegel, 1966, Biochem. Biophys. Acta, 112, 346
- Moore, 1963, J. Biol. Chem., 238, 235, 10.1016/S0021-9258(19)83985-6 · DOI
- Warren, 1959, J. Biol. Chem., 234, 1971, 10.1016/S0021-9258(18)69851-5 · DOI
- Yonetani, 1972, J. Biol. Chem., 247, 2447, 10.1016/S0021-9258(19)45449-5 · DOI
- Brady, 1976, 74, 343
- Hirata, 1976, 74, 354
Cited by
Sorted by citations
Items 201–300 of 308
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy
Tang, K., Wang, B., Yu, B., & Liu, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113967 · Cited by 28
Ziklo, N., Huston, W. M., Taing, K., & Timms, P. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3843-4 · Cited by 25
Notarangelo, F. M., Wang, X., Horning, K. J., & Schwarcz, R. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13455 · Cited by 22
“Since D-TRP is a very poor substrate of tryptophan-2,3-dioxygenase (Watanabe et al. 1980; Batabyal and Yeh 2007), D-KYN production was probably catalyzed by indoleamine-2,3-dioxygenase, which recognizes both LTRP and D-TRP (Tashiro et al. 1961; Shimizu et al. 1978).”
BackgroundSuzuki, T., Yuasa, H. J., & Imai, K. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00059-0 · Cited by 20
4 Aromatic Amino Acids in the Brain
Cansev, M., & Wurtman, R. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-30373-4_4 · Cited by 22
“Data from Smith et al. (1997) that of TDO (i.e., 26 mM [Yamazaki et al., 1985]; 45 mM [Shimizu et al., 1978]), and is active at the tryptophan concentrations found in systemic blood.”
Suzuki, T. (1994) · Journal of Protein Chemistry · doi:10.1007/bf01891987 · Cited by 20
Smeekens, S. P., Henriet, S. S. V., Gresnigt, M. S., Joosten, L. A. B., Hermans, P. W. M., Netea, M. G., Warris, A., & van de Veerdonk, F. L. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0046 · Cited by 20
Wang, D., Saga, Y., Sato, N., Nakamura, T., Takikawa, O., Mizukami, H., Matsubara, S., & Fujiwara, H. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3486 · Cited by 23
“IDO was initially characterized in terms of its catalysis of the first and rate-limiting step in the kynurenine pathway of tryptophan catabolism (1-3).”
BackgroundNatural Product-Inspired Pyranonaphthoquinone Inhibitors of Indoleamine 2,3-Dioxygenase-1 (IDO-1)
Bridewell, D. J., Sperry, J., Smith, J. R., Kosim-Satyaputra, P., Ching, L.-M., Jamie, J., & Brimble, M. (2013) · Australian Journal of Chemistry · doi:10.1071/ch12393 · Cited by 20
Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer’s disease
Sharma, R., Razdan, K., Bansal, Y., & Kuhad, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1524877 · Cited by 22
“IDO is a monomeric heme containing glycoprotein [210] inducing the catalytic cleavage of 2,3-double bond”
BackgroundMatysik-Woźniak, A., Paduch, R., Turski, W. A., Maciejewski, R., Jünemann, A. G. M., & Ręjdak, R. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.02.020 · Cited by 22
Vitamin B6 prevents cognitive impairment in experimental pneumococcal meningitis
Barichello, T., Generoso, J. S., Simões, L. R., Ceretta, R. A., Dominguini, D., Ferrari, P., Gubert, C., Jornada, L. K., Budni, J., Kapczinski, F. P., et al. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214535896 · Cited by 18
“These proinflammatory cytokines activate the metabolic enzyme indoleamine 2,3-dioxygenase,(27) which is widely expressed in all tissues including epithelial cells, macrophages, and dendritic cells.(28) Indoleamine 2,3-dioxygenase in microglia catabolizes the amino acid L-tryptophan to kynurenine.”
BackgroundExpression of indoleamine 2,3-dioxygenase in the rhesus monkey and common marmoset.
Drenzek, J., Breburda, E., Burleigh, D., Bondarenko, G., Grendell, R. L., & Golos, T. (2008) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2008.03.005 · Cited by 19
“In a previous study using the hesus monkey, endometrial CD3+ T cells increased ignificantly from the proliferative phase to day 19 of regnancy and significantly then decreased by day 36 f pregnancy compared with the proliferative phase Slukvin et al., 2004).”
MethodHOLMES, E. W. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.509 · Cited by 18
Malina, H. Z., & Martin, X. D. (1993) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02044236 · Cited by 24
“The role of methylene blue is as an electron carrier from ascorbic acid to ferric enzyme [24], and in the tissues this role is played by dihydroflavin mononucleotide [18].”
BackgroundFlohr, T., Bange, F. C., Euch, A. V., Kiekenbeck, M., & Böttger, E. C. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.4418-4421.1992 · Cited by 18
Cell based functional assays for IDO1 inhibitor screening and characterization
Richards, T., & Brin, E. (2018) · Oncotarget · doi:10.18632/oncotarget.25720 · Cited by 20
“Indoleamine-2,3-dioxygenase (IDO or IDO1) is an intracellular monomeric, heme-containing enzyme catalyzing the conversion of L-tryptophan (L-Trp) to N-formylkynurenine - the first and rate-limiting step of the L-Trp catabolic pathway [1].”
BackgroundOh, J., Shim, K., Lee, J.-I., Choi, S.-I., Baik, S., & Eom, Y. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3043 · Cited by 17
“As another mechanism with which inhibit fibrosis, it is important to inhibit the proliferation of activated HSCs and MFs. Indoleamine 2,3-dioxygenase (IDO) is a rate-limiting enzyme that catabolizes tryptophan to kynurenine, leading to tryptophan depletion (21) and suppresses the growth of pathogens”
Takegawa, D., Nakanishi, T., Hirao, K., Yumoto, H., Takahashi, K., & Matsuo, T. (2014) · Journal of Endodontics · doi:10.1016/j.joen.2014.03.018 · Cited by 17
Paglino, A., Lombardo, F., Arcà, B., Rizzi, M., & Rossi, F. (2008) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2008.05.011 · Cited by 17
Shirey, K., Jung, J., & Carlin, J. (2006) · Infection and Immunity · doi:10.1128/iai.00505-06 · Cited by 17
Weiss, G., Lutton, J., Fuchs, D., Werner-Felmayer, G., Bock, G., Abraham, N., Kappas, A., Levere, R., & Wachter, H. (1993) · Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine · doi:10.3181/00379727-202-43561 · Cited by 17
Meyer, K., Cornwell, R., Carlin, J., Powers, C., Irizarry, A., Byrne, G., & Borden, E. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/6.6.639 · Cited by 17
Placental expression of indoleamine 2,3-dioxygenase
Sedlmayr, P., & Blaschitz, A. (2012) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-012-0082-3 · Cited by 16
“The enzyme indoleamine 2,3-dioxygenase-1 (IDO1), encoded by the INDO gene, catalyzes the first and rate-limiting step of the kynurenine pathway of the essential amino acid L-tryptophan, the oxidization of the pyrrole moiety of tryptophan to N-formylkynurenine [1].”
BackgroundReniers, J., Meinguet, C., Moineaux, L., Masereel, B., Vincent, S. P., Frédérick, R., & Wouters, J. (2011) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2011.09.042 · Cited by 16
2,5-Dihydro-L-phenylalanine: a competitive inhibitor of indoleamine 2,3-dioxygenase.
Watanabe, Y., Fujiwara, M., Hayaishi, O., Takeuchi, T., & Umezawa, H. (1978) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/s0006-291x(78)80039-4 · Cited by 16
Self-citationIndoleamine 2,3-dioxygenase in lung allograft tolerance.
Meloni, F., Giuliano, S., Solari, N., Draghi, P., Miserere, S., Bardoni, A., Salvini, R., Bini, F., & Fietta, A. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.07.023 · Cited by 15
Tryptophan Metabolism Along the Kynurenine Pathway in Rats
Allegri, G., Ragazzi, E., Bertazzo, A., Costa, C., & Rocchi, R. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_56 · Cited by 13
Immunotherapy of Multiple Myeloma: Promise and Challenges
Abramson, H. N. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s306103 · Cited by 19
Tran, H., Shin, E., Saito, K., Tran, T.-V., Phan, D., Sharma, N., Kim, D. W., Choi, S. Y., Jeong, J. H., Jang, C., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110986 · Cited by 15
Geng, J., Weitz, A. C., Dornevil, K., Hendrich, M. P., & Liu, A. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00179 · Cited by 17
Brain Kynurenine Pathway and Functional Outcome of Rats Resuscitated From Cardiac Arrest
Lucchetti, J., Fumagalli, F., Olivari, D., Affatato, R., Fracasso, C., Giorgio, D. D., Perego, C., Motta, F., Passoni, A., Staszewsky, L., et al. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.121.021071 · Cited by 12
Holtzhausen, A., Zhao, F. L., Evans, K. S., & Hanks, B. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00438 · Cited by 12
“INTRODUCTION Indoleamine 2,3-dioxygenase-1 (IDO) is a heme-containing enzyme known to catalyze the rate limiting step in the degradation of the essential amino acid tryptophan to its metabolic byproducts known collectively as the kynurenines (1).”
BackgroundDecreased protein nitration in macrophages that overexpress indoleamine 2, 3-dioxygenase
Keskin, D. B., Marshall, B., Munn, D. H., Mellor, A. L., & Gearhart, D. A. (2006) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-006-0048-9 · Cited by 12
Mutation of cysteine residues alters the heme-binding pocket of indoleamine 2,3-dioxygenase-1.
Austin, C. J. D., Kosim-Satyaputra, P., Smith, J. R., Willows, R., & Jamie, J. (2013) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2013.05.119 · Cited by 11
Modulation of the Kynurenine Pathway for the Potential Treatment of Neurodegenerative Diseases
Courtney, S. M., & Scheel, A. (2010) · Topics in medicinal chemistry · doi:10.1007/7355_2010_9 · Cited by 11
“IDO is a key enzyme in the degradation of tryptophan in extra-hepatic tissues [37], through the generation of N-formyl kynurenine which is further degraded to kynurenine (L-KYN) by formamidase.”
BackgroundRegulatory control and catalytic mechanisms of L-tryptophan 2,3-dioxygenase (pyrrolase).
Ishimura, Y., Makino, R., & Iizuka, T. (1980) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(80)90021-7 · Cited by 11
Enzyme activities along the kynurenine pathway in mice.
Allegri, G., Ragazzi, E., Bertazzo, A., & Costa, C. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_57 · Cited by 10
Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
Gao, Q., DeLaura, I. F., Anwar, I. J., Kesseli, S. J., Kahan, R., Abraham, N., Asokan, A., Barbas, A. S., & Hartwig, M. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931524 · Cited by 11
Sugiura, M., Yuasa, H., & Harumoto, T. (2017) · Protist · doi:10.1016/j.protis.2017.09.003 · Cited by 9
Tryptophan Catabolites and Migraine
Bohár, Z., Párdutz, Á., & Vécsei, L. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151214105439 · Cited by 10
“Besides TRP, it can also utilize D-tryptophan, 5-hydroxy-L-kynurenine, 5-hydroxy-D-kynurenine, melatonin [7] and serotonin [8].”
BackgroundGutiérrez, G., Fitzgerald, J. S., Pöhlmann, T., Hoppe, I., & Markert, U. R. (2003) · American Journal of Reproductive Immunology · doi:10.1111/j.1572-0241.2004.40012.x-i1 · Cited by 6
“It has also been demonstrated that MCSF induces synthesis of the enzyme indoleamine 2,3-dioxygenase (IDO), which catalyzes the initial step of the oxidative metabolism of Trp, in macrophages.(3) Moreover, it has been shown that interferon-c and further signals from activated T cells induced macrophage expression of ID…”
IDO in Inflammatory Programming and Immune Suppression in Cancer
Prendergast, G. C., Smith, C., Thomas, S., Mandik‐Nayak, L., Laury‐Kleintop, L. D., Metz, R. A., & Muller, A. J. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_11 · Cited by 8
Torres-Martínez, L., Morales-Primo, A. U., & Zamora‐Chimal, J. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2511079 · Cited by 7
Cerejo, M., Andrade, G., Roca, C., Sousa, J., Rodrigues, C., Pinheiro, R., Chatterjee, S., Vieira, H., & Calado, P. (2012) · Journal of biomolecular screening · doi:10.1177/1087057112452595 · Cited by 8
“Indoleamine 2,3-dioxygenase 1 (IDO1) is an intracellular heme-containing enzyme that catalyzes the first and ratelimiting step of the kynurenine pathway, through which 95% of the nondietary tryptophan (trp) is metabolized.(1) Expression of IDO is upregulated by proinflammatory cytokines and can be detected in a variet…”
BackgroundShibata, K., Ohno, T., Sano, M., & Fukuwatari, T. (2014) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.60.261 · Cited by 8
Structure-activity Relationship of Indomethacin Derivatives as IDO1 Inhibitors
Obata, T., Shiratani, S., Nada, T., Kasaya, Y., Arisawa, M., Shuto, S., & Tanaka, M. (2021) · Anticancer Research · doi:10.21873/anticanres.15004 · Cited by 7
Jung, J., Yoon, H., Sohn, T.-I., Jang, K., Yoo, Y., Jeong, I., Shin, J. E., Lee, J. H., Ann, J., & Lee, J. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127963 · Cited by 8
Maeta, A., Sano, M., Fukuwatari, T., Funakoshi, H., Nakamura, T., & Shibata, K. (2014) · Bioscience, biotechnology and biochemistry · doi:10.1080/09168451.2014.905185 · Cited by 7
Allegri, G., Ragazzi, E., Costa, C., Caparrotta, L., Biasiolo, M., Comai, S., & Bertazzo, A. (2004) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cccn.2004.06.026 · Cited by 7
Kitamura, S., Shimizu, T., & Ishihara, Y. (1979) · The Journal of pharmacy and pharmacology · doi:10.1111/j.2042-7158.1979.tb13421.x · Cited by 7
Self-citationYoshida, R., & Hayaishi, O. (1984) · doi:10.1016/s0076-6879(84)05009-6 · Cited by 7
Self-citationYuasa, H., Sugiura, M., & Harumoto, T. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.12.019 · Cited by 6
Ibana, J. A., Cutay, S. J., Romero, M., & Schust, D. J. (2015) · Reproductive Sciences · doi:10.1177/1933719115602762 · Cited by 5
Translating Metabolic Reprogramming into New Targets for Kidney Cancer
Aboud, O. A., & Weiss, R. H. (2017) · Kidney Cancer · doi:10.3233/kca-170014 · Cited by 5
A method for the determination of d-kynurenine in biological tissues
Wang, X.-D., Horning, K. J., Notarangelo, F. M., & Schwarcz, R. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7399-7 · Cited by 5
Effect of L-Tryptophan Supplementation on Eosinophils and Eotaxin in Guinea Pigs
Stahl, J., Cook, E., Pariza, M. A., Cook, M., & Graziano, F. (2001) · Experimental biology and medicine · doi:10.1177/153537020122600304 · Cited by 5
Henry, Y. (1997) · Springer eBooks · doi:10.1007/978-1-4613-1185-0_7 · Cited by 5
Assandri, A., Tarzia, G., Bellasio, E., Ciabatti, R., Tuan, G., Ferrari, P., Zerilli, L., Lanfranchi, M., & Pelizzi, G. (1987) · Xenobiotica; the fate of foreign compounds in biological systems · doi:10.3109/00498258709043963 · Cited by 5
Umeda, R., Ito, Y., Minatoguchi, S., Koide, S., Takahashi, K., Hayashi, H., Hasegawa, M., Yuzawa, Y., Yamamoto, Y., Saito, K., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501800r · Cited by 5
“Indoleamine 2,3-dioxygenase (IDO), which has two isoforms—IDO1 and IDO2—serves as the rate-limiting enzyme in the kynurenine pathway [2, 3].”
Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition
Kassab, S. E., & Mowafy, S. (2021) · ChemMedChem · doi:10.1002/cmdc.202100253 · Cited by 5
Miura, H., Shirokawa, T., Ozaki, N., & Isobe, K. (2010) · Health · doi:10.4236/health.2010.23032 · Cited by 4
“Because IDO can directly metabolize 5-HT [12], activated IDO may also decrease 5-HT levels [13].”
BackgroundIndoleamine 2,3‐Dioxygenase: Properties and Functions of a Superoxide Utilizing Enzyme
Hayaishi, O., Takikawa, O., & Yoshida, R. (2007) · doi:10.1002/9780470166390.ch2 · Cited by 4
Self-citationRagazzi, E., Costa, C., Comai, S., Bertazzo, A., Caparrotta, L., & Allegri, G. (2006) · Life Science · doi:10.1016/j.lfs.2005.05.077 · Cited by 4
Fongsaran, C., Dineley, K. T., Paessler, S., & Cisneros, I. E. (2024) · Pathogens · doi:10.3390/pathogens13050397 · Cited by 3
RETRACTED: Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
Xie, L., & Wang, F. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1638060 · Cited by 5
RetractedChen, C.-J., Kimble, B., Aggelen, A. V., Fischer, S., Flanagan, C., Gillett, A. K., Reed, J., Wakeman, J., & Govendir, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314945 · Cited by 2
Sthoeger, Z. M., Sharabi, A., Zinger, H., Asher, I., & Mozes, E. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.08.012 · Cited by 3
Yamano, T., Miura, R., Kanashiro, M., & Uemura, T. (1988) · doi:10.1016/0045-2068(88)90008-9 · Cited by 3
Assandri, A., Perazzi, A., Bellasio, E., Ciabatti, R., Tarzia, G., Ferrari, P., Ripamonti, A., Tuan, G., & Zerilli, L. (1985) · Xenobiotica; the fate of foreign compounds in biological systems · doi:10.3109/00498258509049102 · Cited by 3
Kynurenine pathway enzymes in guinea pigs.
Allegri, G., Costa, C., Ragazzi, E., Bertazzo, A., & Biasiolo, M. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_54 · Cited by 3
EPR Detection of Nitrosylated Compounds : Introduction with some Historical Background
Henry, Y. A., & Guissani, A. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5081-5_1 · Cited by 2
Occurrence of indoleamine 2,3-dioxygenase in human cutaneous malignant melanoma.
Bertazzo, A., Costa, C., Lise, M., Nitti, D., & Allegri, G. (1996) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4613-0381-7_80 · Cited by 3
Chakraborty, A. K., CHAKRABORTY, D. P., & Chakraborty, D. P. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90477-k · Cited by 4
The high-affinity tryptophan uptake transport system in human cells
Wakasugi, K., & Yokosawa, T. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230742 · Cited by 4
Down-regulation of the indoleamine 2,3-dioxygenase (IDO) transcription by tryptophan analogues
Okamoto, T., Toné, S., Kanouchi, H., Ohyama, F., & Minatogawa, Y. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.015
Muller, A. J., Metz, R. A., & Prendergast, G. C. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.042 · Cited by 3
Reproductive Immunology – an Update
Poehlmann, T., Fitzgerald, J., Busch, S., Schleussner, E., Gutiérrez, G., Blois, S., Arck, P., Engert, S., Kämmerer, U., Szekeres-Bartho, J., et al. (2006) · Transfusion Medicine and Hemotherapy · doi:10.1159/000096044 · Cited by 2
Molecular Imaging of Tryptophan Metabolism in Tumors
Juhász, C., & Mittal, S. (2015) · doi:10.1007/978-3-319-11870-3_28 · Cited by 2
Muller, A. J., Smith, C., Metz, R. A., & Prendergast, G. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00032-4 · Cited by 1
General Discussion: Crossregulations of Metalloenzymes Triggered by Nitric Oxide
Henry, Y. (1997) · Springer eBooks · doi:10.1007/978-1-4613-1185-0_15 · Cited by 2
Liu, L., Li, W., & Ye, S. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201310 · Cited by 1
“30,31 This finding is particularly relevant because the prodrug IAA is a structural derivative of indole.”
Cassiano, L. M. G., de Oliveira, D. B., Candiani, T. M. S., Campi‐Azevedo, A. C., Martins‐Filho, O. A., Kroon, E. G., Kohlhoff, M., & Coimbra, R. S. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156237 · Cited by 1
In Memoriam: Osamu Hayaishi (1920–2015)
Narumiya, S., Shimizu, T., & Yamamoto, S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.e067579 · Cited by 1
Self-citationX-ray structure and reaction mechanism of human indoleamine 2,3-dioxygenase
Sugimoto, H., Oda, S., Otsuki, T., Yotsuya, K., Hino, T., Yoshida, T., & Shiro, Y. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.049 · Cited by 1
Humphrey, M. (2003) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1034/j.1600-0897.2003.00093.x · Cited by 7
No evidence for a physiological role of 5-hydroxykynuramine in chicken hemostasis
Laekeman, G., Claeys, M., Vrints, M., & Herman, A. (1985) · Agents and Actions · doi:10.1007/bf01982886 · Cited by 1
Pyrroles and Their Benzo Derivatives: Structure
Dutta, I., Rachuri, Y., Gonçalves, T. P., Huang, M., & Huang, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818655-8.00003-2
Okada, S. S. (2011) · Universidade de São Paulo · doi:10.11606/t.9.2010.tde-21012011-151605 · Cited by 1
“Apesar de MLT ter sido considerada um substrato de IDO a partir dos primeiros trabalhos de Hayaishi e colaboradores (67, 87), esta ideia foi revista recentemente a partir do trabalho de Boutin e colaboradores (68) que Acido ascórbico Acido dihidro ascórbico”
A tryptophan pyrrole-ring cleavage enzyme in the most primitive eukaryote.
Iwamoto, Y., Lee, I. S. M., Tsubaki, M., & Kido, R. (1996) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4613-0381-7_69 · Cited by 1
Schomburg, D., & Stephan, D. (1994) · doi:10.1007/978-3-642-57942-4_10 · Cited by 1
Janus Reactivity of a Mononuclear Non‐Heme Iron(III)‐Peroxo Complex Toward Indole Oxidation
Zhu, W., Wu, P., Wang, B.-J., Ray, K., & Nam, W. (2026) · Angewandte Chemie · doi:10.1002/anie.1874384
“In contrast, IDO features a less restrictive active site, allowing broader tolerance toward structurally diverse indole-containing substrates and related analogues, such as L-Trp, D-Trp, serotonin, melatonin, and tryptamine [16–19].”
Liu, L.-R., & Ye, S. (2026) · Protein Expression and Purification · doi:10.1016/j.pep.2026.106952
Métabolisme du tryptophane : voie de la kynurénine
Launay, J., & Vodovar, N. (2026) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(25)48374-5
Action mechanism and molecular design of indolepyrrodione inhibitors targeting IDO1
Wang, X.-M., Zhang, Z., Hu, K., Yu, W., Cheng, Y., Song, Y.-T., Sun, X., Li, S., Yang, T., Hu, J., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1661700
“Type I, exemplified by 1-methyl-L-tryptophan (1-MT), weakly competes with L-Trp in the distal heme (A) pocket and typically does not form a direct Fe coordination bond (Nakashima et al., 2008; Shimizu et al., 1978).”
Matysik-Woźniak, A., Turski, W., Turska, M., Paduch, R., Łańcut, M., Piwowarczyk, P., Czuczwar, M., Jünemann, A., & Rejdak, R. (2019) · Ophthalmic Research · doi:10.1159/000499021
Kim, K., & Im, S. (2017) · doi:10.15616/bsl.2017.23.3.175
“It has broad substrate specificity for various indoleamines including L-Trp, D-5OH-Kyn, L-5OH-Kyn, tryptamine and serotonin (Hayaishi 1996; Yamamoto and Hayaishi 1967; Shimizu et al., 1978).”
BackgroundRossato, C. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2012.tde-01082012-090046
Seo, S. (2011) · Journal of Life Science · doi:10.5352/jls.2011.21.2.316 · Cited by 1
“IDO의 초기연구는 필수아미노산인 트립토판을 고갈시켜 세포내 기생균과 암세포의 증식을 억제하는 기능이 in vitro에서 보고되었다[21,22].”
Mauron, J., Ganapati, R., Mahadevan, P., & Anantharaman, K. (1992) · Amino Acids · doi:10.1007/bf00805947
Metadata
- Authors
- Shimizu, T., Nomiyama, S., Hirata, F., & Hayaishi, O.
- Affiliations
- Kyoto University (JP)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1978-07
- Volume
- 253
- Issue
- 13
- Pages
- 4700-4706
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1607682771
- Cited by
- 367
- References
- 38
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 9 · 2017: 13 · 2016: 15 · 2015: 12 · 2014: 13 · 2013: 12 · 2012: 20
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- indoleamine 2,3-dioxygenase, enzyme purification, rabbit small intestine, protoheme, sialic acid, carbohydrate content, protein secondary structure, electron spin resonance, tryptophan oxidation, serotonin oxidation, peroxidase activity, guaiacol
- MeSH terms
- Amino Acids, Animals, Electrophoresis, Disc, Hexoses, Hydrogen-Ion Concentration, Indoles, Intestine, Small, Molecular Weight, Oxygenases, Rabbits, Seasons, Substrate Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review